VSV-CT9-M51 showed less neurotoxicity in normal cells than both VSV-CT9 and VSV ΔM51 while retaining the ability to infect, spread within, and kill human GBM in a mouse model after systemic administration, also triggering higher type I IFN dependent responses in the animals [119]. Here, BRDT is linked to glioblastoma.